With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
?Type of Therapeutic Area
?Distribution by Route of Administration
?Key Geographical Regions
?Middle East and North Africa
The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
?Adaptive Phage Therapeutics
Table of Content
4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
6.COMPANY AND DRUG PROFILES
7.CLINICAL TRIAL ANALYSIS
9.PUBLICATION BENCHMARKING ANALYSIS
10.ACADEMIC GRANTS ANALYSIS
11.FUNDING AND INVESTMENT ANALYSIS
12. PARTNERSHIPS AND COLLABORATIONS
13.START-UP HEALTH INDEXING
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
17.APPENDIX I: TABULATED DATA
18.APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
+1 (415) 800 3415Ben.firstname.lastname@example.org
The Safety Syringe and Safety Needles Market Report is a comprehensive report, offering key insights on business strategies, current trends, and presenting...